Metraipolis › archive › dc_ff7bc86b3d35

Synthesis and biological evaluation of novel hydrazone derivatives for the treatment of Alzheimer's disease — Europe PMC PMID:41280213

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41280213
DOI
10.1039/d5ra05755h
License (as archived)
solo-consultazione
Archived
2026-11-08T08:50:21.470Z
SHA-256 of the archived text
6f1266a9f5a689c57e8dfd464f86f48bbf1886066b5ec5b92024686af35f7b9c
Stable URL of this page
https://metraipolis.com/documento/dc_ff7bc86b3d35

How to cite

Synthesis and biological evaluation of novel hydrazone derivatives for the treatment of Alzheimer's disease — Europe PMC PMID:41280213 — Europe PMC (en), https://europepmc.org/article/MED/41280213 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ff7bc86b3d35 (Metraipolis archive dc_ff7bc86b3d35, sha256 6f1266a9f5a689c57e8dfd464f86f48bbf1886066b5ec5b92024686af35f7b9c)
BibTeX
@misc{dcff7bc86b3d35,
  title = {Synthesis and biological evaluation of novel hydrazone derivatives for the treatment of Alzheimer's disease — Europe PMC PMID:41280213},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41280213},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ff7bc86b3d35; sha256 6f1266a9f5a689c57e8dfd464f86f48bbf1886066b5ec5b92024686af35f7b9c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41280213. Agents can read the archived copy with the MCP tool read_document.